🔎 Trials Near Me

Akèy › Obèsite › Oklahoma › Norman

Etid klinik pou Obèsite nan Norman, OK

9 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Norman (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Lynn Institute of Norman, Norman
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Lynn Institute of Norman, Norman
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Ap rekriteFaz 2
  • Alliance for Multispecialty Research, LLC, Norman
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Moore · 9 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Alliance for Multispecialty Research - Norman, Norman
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Norman
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07284979

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Moore · 9 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Ap rekriteFaz 2
  • AMR Norman, Norman
Laj 18 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT07477704

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Ap rekrite
  • University of Oklahoma, Norman
Laj 18 a 45 · Fanm · Mizajou Jun 24, 2026 · NCT05124808

Etid Obèsite nan lòt vil

Lòt etid nan Norman

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.